The chief medical officer of QurAlis discussed the antisense oligonucleotide therapy QRL-201.
Angela Genge, MD, FRCPC, eMBA
Advertisement
Articles by Angela Genge, MD, FRCPC, eMBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma
2
Autologous Stem Cell Therapy for Alzheimer Disease Advances to Phase 2 After Positive Early Findings
3
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
4
ImmunoLogic, Episode 7: "Turbocharging CAR T-Cells: The IL-9 Orthogonal Signal" With Anusha Kalbasi, MD
5
